https://www.selleckchem.com/pr....oducts/1-methyl-3-ni
A significantly different prevalence was found in the BETHESDA IV between Asian/Eastern (2%) and Western (19%) studies. Two-thirds of focal F-FDG TIs undergoing FNA have either malignant (BETHESDA VI) or benign (BETHESDA II) cytology while a minority will have indeterminate (BETHESDA III or IV) FNA results. Significant differences between Asian/Eastern and Western studies are also present in the prevalence of indeterminate FNA results. Two-thirds of focal 18F-FDG TIs undergoing FNA have either malignant (BETH
Like
Comment
Share
